From the Helm: CSL’s David Lamont on the biotech giant’s bright future

Jessica Amir
February 20, 2020

In the latest instalment of Bell Direct’s From the Helm series, Jess has a chat with CSL’s CFO David Lamont.

David gives the inside scoop on CSL, the market leader in the blood plasma and vaccine market. Additionally, he explains CSL’s own products, programmes and partnerships, and the steps taken by the medical giant to tackle coronavirus.

Plus, he sheds some light on the unique situation the broader pharmaceuticals industry finds itself in when it comes to new competition, as well as CSL’s future proofing strategy.

Weekly Wrap 14 August

Bell Direct
August 14, 2020

Morning Bell 14 August

Jessica Amir
August 14, 2020

Morning Bell 13 August

Bell Direct
August 13, 2020

Morning Bell 12 August

Jessica Amir
August 12, 2020

Morning Bell 11 August

Jessica Amir
August 11, 2020

Morning Bell 10 August

Paulina Peters
August 10, 2020

Weekly Wrap 7 August

Bell Direct
August 7, 2020